OCUL

Ocular Therapeutix (OCUL)

Ocular Therapeutix Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:OCUL

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/18	05 : 12	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:OCUL	Ocular Therapeutix Inc
2024/06/14	22 : 03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OCUL	Ocular Therapeutix Inc
2024/06/14	05 : 05	GlobeNewswire Inc.	Ocular Therapeutix™ Highlights Exceptional AXPAXLI™ SOL-1 Enrollment and Plans for Repeat Dosing Study (SOL-R) in wet AMD at Investor Day, Along with Positive 48-week Data from HELIOS NPDR Study	NASDAQ:OCUL	Ocular Therapeutix Inc
2024/06/05	20 : 30	GlobeNewswire Inc.	Ocular Therapeutix® to Host Investor Day on June 13, 2024	NASDAQ:OCUL	Ocular Therapeutix Inc
2024/06/05	06 : 28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OCUL	Ocular Therapeutix Inc
2024/06/05	06 : 26	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:OCUL	Ocular Therapeutix Inc
2024/06/05	05 : 05	GlobeNewswire Inc.	Ocular Therapeutix® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:OCUL	Ocular Therapeutix Inc
2024/06/03	22 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OCUL	Ocular Therapeutix Inc
2024/05/31	06 : 17	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:OCUL	Ocular Therapeutix Inc
2024/05/30	05 : 33	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:OCUL	Ocular Therapeutix Inc
2024/05/29	06 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OCUL	Ocular Therapeutix Inc
2024/05/29	06 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OCUL	Ocular Therapeutix Inc
2024/05/24	05 : 18	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:OCUL	Ocular Therapeutix Inc
2024/05/24	05 : 16	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:OCUL	Ocular Therapeutix Inc
2024/05/08	05 : 22	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:OCUL	Ocular Therapeutix Inc
2024/05/08	05 : 20	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:OCUL	Ocular Therapeutix Inc
2024/05/08	05 : 05	GlobeNewswire Inc.	Ocular Therapeutix™ Reports First Quarter 2024 Results	NASDAQ:OCUL	Ocular Therapeutix Inc
2024/05/08	05 : 01	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:OCUL	Ocular Therapeutix Inc
2024/05/07	09 : 16	GlobeNewswire Inc.	Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:OCUL	Ocular Therapeutix Inc
2024/05/06	20 : 30	GlobeNewswire Inc.	Ocular Therapeutix™ to Present at Two Upcoming Investor Conferences	NASDAQ:OCUL	Ocular Therapeutix Inc
2024/05/03	20 : 30	GlobeNewswire Inc.	Ocular Therapeutix™ To Present at Two Ophthalmology Meetings, May 4-9, 2024	NASDAQ:OCUL	Ocular Therapeutix Inc
2024/05/01	20 : 30	GlobeNewswire Inc.	Ocular Therapeutix™ to Host Investor Day in New York City on Thursday, June 13, 2024	NASDAQ:OCUL	Ocular Therapeutix Inc
2024/03/12	05 : 23	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:OCUL	Ocular Therapeutix Inc
2024/03/12	05 : 12	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:OCUL	Ocular Therapeutix Inc
2024/03/12	05 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OCUL	Ocular Therapeutix Inc
2024/03/11	19 : 39	IH Market News	U.S. Index Futures Dip Ahead of Inflation Data and Oracle’s Earnings; Oil Prices Edge Higher	NASDAQ:OCUL	Ocular Therapeutix Inc
2024/02/28	06 : 43	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OCUL	Ocular Therapeutix Inc
2024/02/27	10 : 07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OCUL	Ocular Therapeutix Inc
2024/02/27	10 : 06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OCUL	Ocular Therapeutix Inc
2024/02/27	10 : 04	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:OCUL	Ocular Therapeutix Inc